Cargando…

Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data

BACKGROUND: Appropriate service delivery, access to high quality of cares and optimal management of type 2 diabetes mellitus (T2DM) can decrease the risk of micro and macro vascular complications and mortality. Therefore, monitoring the quality of diabetes care, including keeping glycemic levels at...

Descripción completa

Detalles Bibliográficos
Autores principales: Davari, Majid, Bayazidi, Yahya, Kebriaeezadeh, Abbas, Esteghamati, Alireza, Bandarian, Fatemeh, Kashi, Zahra, Bahar, Adele, Yousefi, Sepideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112515/
https://www.ncbi.nlm.nih.gov/pubmed/35578191
http://dx.doi.org/10.1186/s12902-022-01034-2
_version_ 1784709427281002496
author Davari, Majid
Bayazidi, Yahya
Kebriaeezadeh, Abbas
Esteghamati, Alireza
Bandarian, Fatemeh
Kashi, Zahra
Bahar, Adele
Yousefi, Sepideh
author_facet Davari, Majid
Bayazidi, Yahya
Kebriaeezadeh, Abbas
Esteghamati, Alireza
Bandarian, Fatemeh
Kashi, Zahra
Bahar, Adele
Yousefi, Sepideh
author_sort Davari, Majid
collection PubMed
description BACKGROUND: Appropriate service delivery, access to high quality of cares and optimal management of type 2 diabetes mellitus (T2DM) can decrease the risk of micro and macro vascular complications and mortality. Therefore, monitoring the quality of diabetes care, including keeping glycemic levels at an optimal level, is crucial. The aim of this study was to evaluate processes and outcome-related quality of care indicators, in T2DM using retrospective patient-level data from 2013 to 2017 in 15 Tertiary Diabetes Care Centers in Iran. METHOD: A retrospective observational study was conducted among 1985 T2DM patients at public, semipublic and private diabetes centers. Annual tests for HbA1c, serum lipid (LDL), and screening for nephropathy were used to evaluate process-related indicators; and intermediate biomedical markers including HbA1c, blood pressure (BP), and LDL cholesterol, were used to assess outcome-related indicators. RESULTS: Data were extracted from 15 diabetes centers in five provinces in Iran. 62.7% of the patients were female, and the mean duration of diabetes in the patients was 14.7 years. Evaluation of process-related indicators showed that only 9% of patients took the HbA1c test. The percentage of the patients without annual low-density lipoprotein (LDL) test decreased from 13% in 2013 to 7% in 2017. The results of achieving to all indicators concurrently (ABC care) showed that less than 2% of the patients met the criteria of optimal process-related quality indicators. The mean percentage of the patients with HbA1c under 7%, blood pressure (BP) less than 130/80 mmHg, and LDL less than 100 mg(/dl) in the selected provinces were 32.4, 55, and 71 respectively. However, the average of total achievement in ABC goals was 14.2%. CONCLUSION: Our findings showed that the management of T2DM in all selected provinces was far from the optimal control in both processes and outcome-related indicators and therefore needs serious consideration and improvement.
format Online
Article
Text
id pubmed-9112515
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91125152022-05-18 Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data Davari, Majid Bayazidi, Yahya Kebriaeezadeh, Abbas Esteghamati, Alireza Bandarian, Fatemeh Kashi, Zahra Bahar, Adele Yousefi, Sepideh BMC Endocr Disord Research BACKGROUND: Appropriate service delivery, access to high quality of cares and optimal management of type 2 diabetes mellitus (T2DM) can decrease the risk of micro and macro vascular complications and mortality. Therefore, monitoring the quality of diabetes care, including keeping glycemic levels at an optimal level, is crucial. The aim of this study was to evaluate processes and outcome-related quality of care indicators, in T2DM using retrospective patient-level data from 2013 to 2017 in 15 Tertiary Diabetes Care Centers in Iran. METHOD: A retrospective observational study was conducted among 1985 T2DM patients at public, semipublic and private diabetes centers. Annual tests for HbA1c, serum lipid (LDL), and screening for nephropathy were used to evaluate process-related indicators; and intermediate biomedical markers including HbA1c, blood pressure (BP), and LDL cholesterol, were used to assess outcome-related indicators. RESULTS: Data were extracted from 15 diabetes centers in five provinces in Iran. 62.7% of the patients were female, and the mean duration of diabetes in the patients was 14.7 years. Evaluation of process-related indicators showed that only 9% of patients took the HbA1c test. The percentage of the patients without annual low-density lipoprotein (LDL) test decreased from 13% in 2013 to 7% in 2017. The results of achieving to all indicators concurrently (ABC care) showed that less than 2% of the patients met the criteria of optimal process-related quality indicators. The mean percentage of the patients with HbA1c under 7%, blood pressure (BP) less than 130/80 mmHg, and LDL less than 100 mg(/dl) in the selected provinces were 32.4, 55, and 71 respectively. However, the average of total achievement in ABC goals was 14.2%. CONCLUSION: Our findings showed that the management of T2DM in all selected provinces was far from the optimal control in both processes and outcome-related indicators and therefore needs serious consideration and improvement. BioMed Central 2022-05-17 /pmc/articles/PMC9112515/ /pubmed/35578191 http://dx.doi.org/10.1186/s12902-022-01034-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Davari, Majid
Bayazidi, Yahya
Kebriaeezadeh, Abbas
Esteghamati, Alireza
Bandarian, Fatemeh
Kashi, Zahra
Bahar, Adele
Yousefi, Sepideh
Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
title Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
title_full Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
title_fullStr Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
title_full_unstemmed Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
title_short Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
title_sort quality of care in type 2 diabetes in iran; a cross-sectional study using patient-level data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112515/
https://www.ncbi.nlm.nih.gov/pubmed/35578191
http://dx.doi.org/10.1186/s12902-022-01034-2
work_keys_str_mv AT davarimajid qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT bayazidiyahya qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT kebriaeezadehabbas qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT esteghamatialireza qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT bandarianfatemeh qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT kashizahra qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT baharadele qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata
AT yousefisepideh qualityofcareintype2diabetesiniranacrosssectionalstudyusingpatientleveldata